EA
FCSC

Emerald Advisers’s Fibrocell Science Inc. FCSC Stock Holding History

Emerald Advisers’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21,670
Closed -$1.48M – 340
2015
Q4 		$1.48M Buy
21,670
+42
+0.2% +$3.02K 0.07% 225
2015
Q3 		$1.25M Buy
21,628
+5,458
+34% +$483K 0.07% 238
2015
Q2 		$1.28M Sell
16,170
-108
-0.7% -$7.27K 0.06% 232
2015
Q1 		$852K Buy
+16,278
New +$1.05M 0.04% 259

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Advisers's FCSC Position: Q1 2016 in Review

Emerald Advisers sold out of Fibrocell Science Inc. (FCSC) in Q1 2016, closing a stake of 21,670 shares — an estimated $1.48M sold.

Emerald Advisers first reported a position in FCSC in Q1 2015 and held it in 4 quarters. The position peaked at $1.48M in Q4 2015. 52 funds tracked by Wall St. Rank hold FCSC as of Q1 2016.

  • Emerald Advisers reported no remaining Fibrocell Science Inc. position as of Q1 2016 after selling out during the quarter.
  • Emerald Advisers sold 21,670 Fibrocell Science Inc. shares in Q1 2016, an estimated $1.48M.
  • Emerald Advisers first reported a position in Fibrocell Science Inc. in Q1 2015 and held it in 4 quarters.
  • Emerald Advisers's Fibrocell Science Inc. position peaked at $1.48M in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2016.

Based on Emerald Advisers's 13F filing for Q1 2016, filed 28 Apr 2016.